Pharma Deals Review, Vol 2003, No 40 (2003)

Font Size:  Small  Medium  Large

Merck Backs Alnylam’s RNAi Technology

Business Review Editor

Abstract


Merck and Alnylam Holding entered into multiyear research collaboration to develop new drugs using Alnylam’s RNA interference (RNAi) Technology.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.